Ongoing projects

    • EU Horizon Europe collaborative project (1/2023 – 12/2028): Inflammation in human early life: targeting impacts on life-course health (INITIALISE) – Coordinator (Oresic)
    • Academy of Finland: Human exposure to per- and poly-fluoroalkyl substances – role of the gut microbiome and bile acid metabolism in mediating impact (PFASgut) – PI (Oresic)
    • Collaborative project, Innovative Medicines Initiative: Translational approaches to disease modifying therapy of type 1 diabetes- HARVESTing the fruits of INNODIA (INNODIA HARVEST) – Participant (Oresic)
    • COST action CA19105, Horizon 2020 Programme. LipidNET- Pan-European Network in Lipidomics and Epilipidomics. Working Group leader (Oresic), Clinical significance and applications of (epi)lipidomics
    • Academy of Finland (Postdoctoral Research project): Metabolomics meet gut microbiome. A stepping stone towards type 1 diabetes prediction and prevention – PI (Lamichhane)
    • Vetenskapsrådet: Blood-based metabolomics to predict severity and patient outcomes in traumatic brain injury – PI (Oresic)
    • Collaborative project, EU Horizon 2020 Innovative Medicines Initiative: Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) – Metabolomics Task Force leader (Oresic)